KA
ABBV icon

Kooman & Associates’s AbbVie ABBV Stock Holding History

Kooman & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Buy
3,417
+159
+5% +$34.2K 0.23% 26
2026
Q1 		$709K Sell
3,258
-30
-0.9% -$6.66K 0.21% 25
2025
Q4 		$751K Sell
3,288
-187
-5% -$42.6K 0.22% 24
2025
Q3 		$805K Sell
3,475
-1
-0% -$204 0.25% 23
2025
Q2 		$645K Buy
3,476
+40
+1% +$7.43K 0.22% 25
2025
Q1 		$720K Buy
3,436
+25
+0.7% +$4.86K 0.26% 22
2024
Q4 		$606K Buy
3,411
+195
+6% +$35.9K 0.22% 25
2024
Q3 		$635K Sell
3,216
-14
-0.4% -$2.61K 0.23% 24
2024
Q2 		$554K Sell
3,230
-16
-0.5% -$2.65K 0.22% 24
2024
Q1 		$591K Sell
3,246
-132
-4% -$22.7K 0.25% 23
2023
Q4 		$523K Buy
3,378
+36
+1% +$5.25K 0.23% 26
2023
Q3 		$498K Buy
3,342
+13
+0.4% +$1.91K 0.25% 25
2023
Q2 		$449K Sell
3,329
-207
-6% -$30.4K 0.22% 26
2023
Q1 		$564K Buy
3,536
+15
+0.4% +$2.29K 0.3% 21
2022
Q4 		$569K Buy
+3,521
New +$540K 0.56% 21

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Kooman & Associates's ABBV Position: Q2 2026 in Review

Kooman & Associates increased its AbbVie (ABBV) stake by 4.9% in Q2 2026, buying an estimated $34.2K and bringing the position to 3,417 shares worth $860K. The position accounts for 0.23% of the portfolio, ranked #26.

Kooman & Associates first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kooman & Associates held 3,417 shares of AbbVie worth $860K as of Q2 2026.
  • Kooman & Associates bought 159 AbbVie shares in Q2 2026, an estimated $34.2K.
  • AbbVie made up 0.23% of Kooman & Associates's portfolio in Q2 2026, its #26 holding.
  • Kooman & Associates first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kooman & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.